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What You NEED to Know about HIV/AIDS
Lauren McClain, BSN, RN
Otterbein University, Westerville, Ohio
Introduction
Thirty years ago, the human
immunodeficiency virus (HIV) was
recognized as the cause of acquired
immune deficiency syndrome (AIDS).
Since that time, HIV/AIDS continues to
be an ongoing problem worldwide. Even
with persistent public heath campaigns
and advancements in antiretroviral
therapy, HIV/AIDS remains a major
cause of global morbidity and mortality
(Aggleton, Yankah, & Crewe, 2011).
Although the annual number of new
HIV/AIDS infections has remained
stable, the number of people living with
HIV/AIDS has continued increased. In
the United States alone, the Centers of
Disease Control and Prevention (CDC)
estimates that 1,201,100 people are
living with HIV infection, in addition to
168,300 (14%) who are unaware of
being infected. In 2013, an estimated
47,352 people were diagnosed with HIV,
while an estimated 26,688 people were
diagnosed with AIDS (CDC, 2015).
HIV/AIDS is disproportionately more
common in certain countries and highrisk groups. Homosexual men, bisexual
men, and intravenous drug users
continue to endure the highest rates of
HIV infection. Homosexual men account
for about 50% of people living with HIV,
and intravenous drug users account for
approximately 25% (Castel, Magnus, &
Greenberg, 2015). Racially, African
American and Latinos account for 45%
of new HIV infections. However,
globally, the epidemic is the most severe
in South Africa. South Africa holds more
than half (70%) of the world’s HIV
population. Fortunately, since 2010,
AIDS-related deaths have decreased
steadily due to free drug treatment. But,
there has been a rapid increase in new
HIV infections in other countries such as:
India, China, Central Asia, Eastern
Europe, and parts of Russia. In Central
Asia and China, the HIV rate as risen
250% over the past 10 years (Moss,
2013).
Although HIV/AIDS infection has
dropped about 20%, the incidence of
infection varies in different parts of the
world. The variation in incidences points
to flawed public perceptions that the
dangers from HIV are declining as a
result of treatment and educational
programs. Therefore, education and
general public awareness are a main
focus when it comes to decreasing the
rate of HIV/AIDS.

Pathophysiology
HIV is a member of the lentivirus
genus. These viruses are characterized
by long latency period and progressive
infection where the virus evades the
immune response of the host. HIV is
transmitted through blood, semen,
vaginal fluids, and breast milk. HIV
infects cells in the immune system and
the central nervous system. More
specifically, HIV infects the CD4 T cells,
also known as T lymphocytes. T cells
play a crucial role in the immune system
to fight infection. Therefore, a significant
reduction in T cells weakens the immune
system. HIV is comprised of two
antigens that are specific to the virus,
gylcoprotein 120 and 41 (gp120 and
gp41). These two antigens bind with
immune cells to initiate the infectious
cycle (Moss, 2013).
In order for the virus to survive and
replicate, the virus must go through
multiple stages.
• Attachment- HIV transmission
begins with the HIV’s gp120 attaching to
the T cell’s surface.
• Penetration- After the virus is
attached, the virus penetrates into the T
cell. Once inside, the capsid proteins are
digested, releasing viral enzymes and
RNA into the cytoplasm of the T cell.
• Reverse Transcription- The HIV
enzyme uses reverse transcriptase to
transforms the viral RNA into singlestranded DNA. It is common for errors
to occur due to poor “proofreading” of
the reverse transcriptase. The process
repeats to create a double-stranded
DNA.

Integration- The newly created
HIV DNA moves into the T cell’s
nucleus and is spit into the host
DNA. Once the viral DNA is
integrated with the host’s DNA,
the DNA is replicated using
normal replication mechanisms.
•
Transcription- Next, HIV uses T
cells to make copies of the virus.
The viral RNA is used as a
template for new viruses and
messenger RNA (mRNA). The
mRNA produces viral proteins
with ribosomes in the cell
cytoplasm. Simultaneous
production of other mRNA allows
for translation of additional viral
proteins, which leads to
maturation of the HIV and an
increased ability to infect the host.
•
Assembly- During assembly, viral
proteins collect at the plasma
membrane, and move together
toward the cells surface.
•
Budding- When the virus reaches
the cells surface, the virus breaks
away from the host cell.
•
Maturation- The cell does not
mature until the HIV protease
enzyme, which was produced
during integration, cuts the viral
multiprotein chains into their
proper size. This leads to a
mature and functional HIV virion
that is able to infect other T cells,
specifically T cells with the cell
marker CD4.
When the new virus leaves the CD4 T
cell, the plasma membrane of the
cell is ruptured and the CD4 cell is
destroyed. Over a period of years,
HIV invades and destroys other T
cells; the host immune system is
weakened, which leads to the
onset of AIDS (Moss, 2013).

Signs and Symptoms

•

Diagnosis
The average detection window for HIV
testing is 25 to 30 days after infection. If an
infected person is using antiretroviral
therapy, antibody formation can be delayed
up to 12 months. A diagnosis of HIV can be
confirmed with several different types of
tests. These tests are designed to detect
antigens, antibodies, or RNA. The original
screening test was used to determine the
presences of enzyme-linked immunosorbent
assay (ELISA). The ELISA test is a two-step
process used to check for antibodies
stimulated by HIV. If the ELISA generates a
positive result, a conformation test is usually
performed. According to the CDC, the ELISA
method is not used to confirm a diagnosis.
The CDC recommends using the more
expensive Western blot test. The Western
blot test also identifies antibodies, but it
identified antibodies of specific molecular
weight, which eliminates false-positive
results. Other tests available are rapid tests
that provide a result within 10 to 20
minutes, or at home tests using an oral
swab. However, any positive result needs to
be confirmed by a Western blot test (Moss,
2013).

HIV occurs in four stages: primary infection, clinically asymptomatic HIV,
possible minor symptoms, and symptomatic HIV.
• Stage I- The first stage of infection only last for a couple of months, it is
common for the infected person to experience no symptoms or have a brief period
of flu-like illness (AIDS.gov, 2015). During this time, there is a high amount of HIV
in the blood, and the immune system responds to the virus by generating HIV
antibodies and cytotoxic lymphocytes. The process of creating antibodies to a
specific antigen is called seroconversion (Moss, 2015).
• Stage II- After seroversion is complete, the infected person will test positive for
HIV. The clinically asymptomatic HIV last an average of 10 years. The individual
usually has no symptoms, except the person may have swollen glands and may
develop psoriasis, shingles, and minor infections. After a prolonged asymptomatic
phase, symptoms begin to show in the infected person (Moss, 2015).
• Stage III- In the symptomatic HIV phase, HIV has significantly damaged the
individual’s immune system. When lymphocyte counts drop to below 200
cells/uL, the person is at risk for multiple infections. Opportunistic infections can
include: pneumonia, diarrhea, eye infections, and meningitis. Having a severely
weakened immune system also increase the risk for various cancers. It is common
for the individual to develop HIV wasting syndrome, which is characterized by
rapid weight loss and weakness (Moss, 2013).
• Stage IV- As the immune system become increasingly impaired, the individual
will progress to AIDS. The symptomatic stage progressing to AIDS lasts from 8 to
12 years (Moss, 2013).

Treatment
At this time there is no cure for HIV. But
with antiretroviral therapy, the course of
HIV can be altered. Enhancements in
treatments have led to fewer HIV-infected
individuals dying of HIV-related illnesses
(Millard, Elliott, & Girdler, 2013). Currently,
there are more than 20 approved
antiretroviral drugs. These drugs aim to
maintain the HIV levels to prevent
weakening of the immune system.
Combination therapy is when the patient is
taking 2 or more antiretrovirals at the same
time. Taking 3 or more antiretrovirals is
called highly active antiretroviral therapy
(HAART). HAART has become the standard
of care in high-income countries. Regimes
normally contain a drug to suppress viral
replication, and a drug to increase CD4
lymphocyte counts. Patient must receive
treatment for life. Negative effects of longterm treatment include diabetes, heart
disease, liver disease, and various forms of
cancer. Although, there is no cure,
antiretrovirals have to possibility to turn
HIV/AIDS into a long-term chronic medical
condition (Moss, 2013).

Nursing
Considerations
In caring for a patient with HIV/AIDS,
it is important for nurses to be educated
on HIV transmission and understand the
virus cannot be transmitted through
common contact. All body fluid should
be considered as potentially infectious,
and standard precautions should be
maintained. Standard precautions
include hand washing, use of personal
protective equipment, and sharps
handling and disposal (Koerich, dos
Santos, Schlindwein Meirelles, &
Erdmann, 2015).

Conclusion
Strategies for HIV/AIDS prevention
and management evolve continually.
Educational programs and treatment are
becoming more effective and efficient.
The only way to prevent new infections
is through education. HIV prevention
programs are being implemented in
nearly all countries (Moss, 2013). In
2011, the United Nations Program on
HIV/AIDS (UNAIDS) mission included
decreasing the sexual transmission of
HIV by 50%, a 50% reduction in AIDSrelated maternal mortality, and the
elimination of new infections via drug
users and vertical transmission (Moss,
2013). With recent achievements and
ambitious goal setting, a HIV-free
generation is possible.
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